BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$0.56 M
• Last year FTD volume: A$0.56 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$3.53 M	A$54.7 M	🇺🇸 USA
Sarepta Therapeutics SRPT	A$8.25 M	A$40.89 M	🇺🇸 USA
NanoViricides NNVC	A$0.74 M	A$3.2 M	🇺🇸 USA
Novavax NVAX	A$21.8 M	A$0.14 B	🇺🇸 USA
Gilead Sciences GILD	A$45.26 M	A$0.22 B	🇺🇸 USA
Celldex Therapeutics CLDX	A$1.22 M	A$6.08 M	🇺🇸 USA
GlaxoSmithKline GSK	A$57.35 M	A$99.79 M	🇬🇧 UK
Emergent BioSolutions EBS	A$1.56 M	A$5.72 M	🇺🇸 USA
Cel-Sci CVM	A$0.45 M	A$2.71 M	🇺🇸 USA